A House committee is holding a hearing on Thursday at which the head of the Food and Drug Administration (FDA) is set to testify on hemp regulatory issues as members aim to hold him “accountable” amid ongoing industry concerns.
The House Oversight and Accountability Committee, chaired by Rep. James Comer (R-KY), announced that it had scheduled the hearing with FDA Commissioner Robert Califf last week.
Members will weigh in on “ongoing investigations” into FDA’s “response to several issues, including…hemp regulation,” the panel said in a notice.
“The Oversight Committee has highlighted several crises occurring on the FDA’s watch which have negatively impacted the lives and health of American people and families,” Comer said in the notice. “We will hold the Commissioner accountable for what the FDA is doing to address ongoing crises, how they are conducting inspections to prevent nationwide crises in the future, and how they intend to ensure the FDA is first and foremost protecting American consumers.”
Califf said in written testimony that while FDA has concluded it lacks proper authority to implement regulations allowing hemp-derived CBD in the food supply or as dietary supplements, “we recognize that consumers want access to these products.”
“That is why FDA announced
Read full article on Marijuana Moment
